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Epidemiology of melanoma in rural southern Queensland
Objective 
The objective of this study is to define the epidemiology of melanoma in rural communities 
in southern Queensland.
Design 
The design used was a 6-year clinical record audit of melanoma cases identified by billing 
records and electronic clinical records, confirmed and typed with histology.  
Setting and Participants
This study was based in seven agricultural communities on the Darling Downs with patients 
presenting to local primary care clinics. 
Main outcome measures
Outcomes measured were confirmed type, depth and anatomic distribution of melanoma 
identified at these practices during the study period.
Results
The results from 317 cases of melanoma found anatomic and subtype distribution was 
different to that reported previously from the Queensland Cancer Registry. A high proportion 
of melanoma-in-situ and lentigo maligna were found in the overall epidemiology of 
melanoma in these rural communities.  
Conclusions
Conclusions drawn from these findings is that melanoma risk is not so much lesser in rural, 
inland communities compared to coastal and metropolitan regions, but different. These 
differences may relate to comprehensive data capture available in rural community studies 
and to different sun exposure and protection behaviours contributing to different subtypes and 
anatomic distribution. 





























































What is already known on this subject
- Cancer morbidity and mortality, including for melanoma, are generally less 
favourable in rural areas of Australia,
- Rural lifestyle and health care access are proposed to contribute to these outcomes, 
and
- No specific epidemiology for inland rural communities is available. 
What this paper adds
- The epidemiology of melanoma in inland rural communities is different to that 
measured state-wide in Queensland,
- The high rate of early stage melanoma found here does not support delays in 
diagnosis in this region,
- Early identification and local management of melanoma in rural general practice 
contributes to different and early stages of melanoma identified, and
- More comprehensive research detailing melanoma epidemiology is possible with 



































































Cancer morbidity and mortality are generally less favourable in rural areas of Australia with 
an estimated additional 9000 deaths in the decade form 2001-2010 compared to metropolitan 
Australia.1 More specifically, an age-adjusted fatality rate for melanoma was found to be 
20% higher in rural areas, attributed to differences in access and management practices in 
rural areas.2 Inner regional areas of Australia have the highest incidence of the four 
commonest notifiable cancers, including melanoma.3 Accordingly, on the eastern Darling 
Downs in Queensland, there is a modest collective rate ratio (1.07) of the five commonest 
cancers recorded (Breast, Colorectal, Lung, Melanoma and Prostate Cancers) compared to the 
Australian population, however, this is largely due to the significantly greater age 
standardised incidence rate (ASIR) of melanoma (87.2/100,000 people) over the Australian 
rate (49.3/100,000).4 Notably, this rate on the Darling Downs is also higher than the 
Queensland ASIR of melanoma (73.3/100,000).5 
The region was noted to have a similar incidence of melanoma to Queensland in 2002, but 
has had a significantly higher rate of increase in melanoma over preceding two decades.6 At 
this time, coastal regions were considered higher risk for melanoma than rural, inland 
regions, due to different sun exposure in the “rural lifestyle”. In fact, by 2014, the region of 
the Darling Downs and West Moreton Primary Health Network (PHN) was alongside the 
Gold Coast PHN reporting highest ASIR of melanoma in Queensland. The reported rates are 
higher than those in (rural) central and northern Queensland and well above western 
Queensland.7 However, there is limited specific epidemiology of the nature and management 
of melanoma presenting in rural inland regions such as the Darling Downs. The largest 
industry in the region is agriculture. Outside the city of Toowoomba, there are rural 
communities which are small (ASGC-RA MMM 4-5) with health care generally delivered 





























































only by primary care providers.8 Considering earlier concerns of specialist care access and a 
rural lifestyle contributing to different melanoma epidemiology the aim of this research was 
to determine the epidemiology and management of melanoma presenting in rural 
communities of the Darling Downs.
Methods
This study used a clinical record audit of melanoma cases identified by billing records in 
rural medical practices in seven rural communities on the Darling Downs over a six-year 
period. These communities included Clifton (population 1456 people in the 2016 Census), 
Warwick (population of 12,222), Pittsworth (3294 residents), Millmerran (1543 residents), 
Kingsthorpe (1867 residents), Oakey (population 4705 people) and Goondiwindi (population 
6,355). While the populations listed reflect the towns, practices also serve surrounding 
farming areas.
Cases were identified by billing records of specific Medicare item numbers for the 
management of melanoma and by review of cases billed for biopsy of a lesion. All cases 
identified from Medicare billing data were linked to histology reports from specialist 
pathologists available through the patient’s electronic clinical record (ECR). For inclusion in 
the study all cases needed to be confirmed and typed from these histology reports.  Typing of 
melanoma was undertaken and categorised using terminology employed by reporting 
histopathologists.
Melanoma cases were included from biopsy when the histology reported melanoma. Caution 
was exercised that individual melanoma were not double counted. Cases of second melanoma 
were scrutinised to determine whether they were second primary or recurrence of an earlier 





























































primary melanoma. Study records were anonymised upon extraction of data from the ECR to 
ensure that identified clinical records did not leave the respective practice. Descriptive 
analysis of histologically-confirmed tumour type is provided with anatomical distribution and 
relative tumour density (RTD) on defined body sites. RTD was calculated by dividing the 
proportion of tumours occurring at a specified site by the proportion of skin area of that site.
The study was approved by the RACGP NREEC and supported with funding by the Skin 
Cancer College of Australasia. Clinical investigators were medical students attached to the 
rural practices where the study was conducted.  The process was overseen by a designated 
clinical supervisor at each practice. 
Results
Overall, 317 melanoma were identified, typed and clinical circumstances reviewed. Patients 
were predominantly males (183, 58%). Ages of these patients ranged from 26 to 102 years 
with a mean age of 68 years (SD 14) for males and 65 years (SD 17) for females. Thirteen 
patients were diagnosed with two primary melanoma in this six-year period of sampling. 
Nine patients were diagnosed with second primary melanomas having a history of earlier 
primary melanoma diagnosed prior to the sampling period. One patient was diagnosed with a 
recurrence of a primary melanoma diagnosed and treated prior to the sample period. 
Therefore there were 294 patients seen with first primary melanoma. They had the same 
gender distribution (42% female). Of these, 13% were melanoma greater than 1mm thick at 
diagnosis. 
Notably, of the 13 patients with two primary melanoma in this period, seven (2% of 294) 
were found to have two lesions diagnosed as melanoma concurrently. One of these patients 
was considered to have a cutaneous metastasis. Patients with more than one melanoma 





























































diagnosed in the period, or a history of melanoma previously, averaged 78 years of age. 
Compared to the Queensland registry data, males were less prevalent in both the total series 
of melanoma cases and individuals with first primary melanoma. 
Table 1: Age distribution of patients diagnosed with melanoma
The patient group diagnosed with melanoma in these Darling Downs communities were 
significantly (χ2=19.8, p<0.01) older (Table 1) than those across the State of Queensland.9
Thirty-one cases were diagnosed on biopsy before definitive excision and 44 cases were 
referred for further care. Referral reasons were for wider margins of excision most 
commonly, and for primary excision following biopsy typically for deeper melanoma. Cases 
with melanoma greater than 1mm depth not referred (n=27) were generally older patients 
(median age 79 years) including many with nodular melanoma (n=13, median age 80 years). 
Table 2: Anatomical distribution and relative tumour density of melanoma  
The anatomic distribution of melanoma diagnosed in these rural communities were found to 
be significantly different (χ2=9.6, p<0.05) (Table 2) to that previously reported from the 
Queensland Cancer Registry.9 Most notable were differences in head and neck and limb 
RTD. In this series, lesions on the trunk were mostly posterior (n=98), not readily detectible 
by the individual. Superficial spreading melanoma were the most commonly diagnosed 
melanoma in this series. These were more distributed to the upper body. They are the most 
common melanoma diagnosed on younger patients and 81/148 (55%) were invasive at 
diagnosis, representing 67% of all invasive melanoma diagnosed. 





























































The highest density of lentigo maligna (LM) tumours was on the head and neck. The average 
age of these patients at diagnosis of LM was 71 years and 23/95 (24%) were invasive at 
diagnosis, representing 19% of invasive melanoma. 
Nodular melanoma were more common among older patients. A high proportion of nodular 
melanoma (17/19, 89%) were invasive at diagnosis representing 14% of invasive melanoma 
found. 
A high proportion (87%) of melanoma diagnosed by these General Practitioners were 1 mm 
or less when treated. These were evenly distributed between males and females.
 
Discussion
This study examines the nature of melanoma presenting in rural communities in southern 
Queensland from clinical data derived from primary care practices. It has illustrated some 
notable differences to previous population-level studies. The seven practices from which 
these cases were drawn serve rural communities - ASGC-RA MMM 5 and one MMM 
category 4 community. The region has a higher median age (40.4 years) than the Australian 
population (37.2 years) and our data has not been age-standardised as the Queensland Cancer 
Registry. Notwithstanding, these findings illustrate differences to the conventional 
epidemiology of melanoma described from population-level studies. These may arise for a 
number of reasons such as the nature of sun exposure and protection in rural communities 
and the model of health services available.
This study has a number of strengths. Using this method we were able to capture more 
comprehensive data at the community level. Completeness of data captured was high and 





























































more detailed with the addition of related clinical and demographic information from the 
ECR. The data is also more specific to the community providing more internally valid 
epidemiological data that could help in making more accurate assumptions about etiology and 
preventive interventions. However, there may be a concurrent risk of reduced external 
validity or generalizability to other rural areas.
In this rural region, a major difference to population-level findings is a gender variation. 
Males (58%) were under-represented in this rural series compared to the 67.5% of 
Queenslanders diagnosed with (first) melanoma in the 2005-2009.8 Depth, level and anatomic 
distribution of melanoma in the Queensland population is available from the Queensland 
Cancer Registry (QCR) and reported in previous studies.8,10 The distributions described in the 
QCR data were also found to be different to that seen in these rural communities. 
Melanoma type varies with the pattern of sun exposure, age and site and site distribution of 
melanoma subtypes have been noted to be changing in Queensland.10,11,12 Compared to this 
large dataset investigating invasive melanoma in the Queensland Cancer Registry from 1982-
2008, we found a lower proportion of invasive superficial spreading melanoma (67%) than 
previously described (78%), but a higher proportion of lentigo melanoma (19%) in this region 
than recorded in the QCR between 1982-2008 (9%) and a comparable proportion of nodular 
melanoma (14%) to Queensland (13%). These distributions, particularly the higher 
proportion of lentigo melanoma, found on the head and neck, likely reflect the chronic sun 
exposure, lower recreational sun exposure and older population in these rural communities 
and is consistent with that previously described for lentigo melanoma.13 





























































Another potential aetiology for variance in these locally generated rural findings is inclusion 
of in situ lesions in the analysis. Approximately half of all SSM and three quarters of LM are 
found in these practices at the in situ stage. Studies from the QCR for the period 1982-2002 
recognize in situ lesions increasing in incidence over the period at a greater rate than invasive 
melanoma.6 The investigators have proposed greater diagnosis in primary care as the 
potential source. From the raw data of the QCR presented in this report, 35% (20,712) were 
in situ melanoma. Our findings certainly support the understanding that in situ lesions are 
increasing as a proportion of melanoma diagnosed, at least in this series generated from 
primary care practice data.
All of these rural community general practices provide services including identification and 
management of melanoma. They tend to find a high proportion of superficial spreading 
melanoma typically among younger patients and high proportion of lentigo maligna 
melanoma, most densely represented on the head and neck, found in the in situ phase of 
growth.  The rate of identification of early lesions is notable with 87% of melanoma 
diagnosed and treated with a depth of 1mm or less. This is markedly greater than the 
proportion of melanoma recorded in the QCR from 1982-2006 (66%), and is also better than 
the proportion previously diagnosed in this range in rural areas of Queensland (69%).2 In this 
study by Coory et al. that investigated rural:urban factors in survival from melanoma, 
proposed upstream factors were socioeconomic disadvantage and downstream factors were 
higher cancer risk factors (smoking, sun exposure) and delays in diagnosis, comorbidities and 
treatment disparities. The high rate of early stage melanoma found here does not support 
delays in diagnosis being as active in this region. 





























































Regarding access to treatment, in this series, most cases were managed locally. A minority of 
cases were referred for further management (n=44, 14%).  Such management in public 
facilities from these communities require patient travel from one to three hours by road. 
Cases not transferred for whom management might be expected to include referral for further 
evaluation of nodal spread (>1mm depth),14 were older patients (median age 79 years) half of 
whom had high-grade nodular melanoma (n=13). Along with depth, these are two major 
negative influential determinants for melanoma survival.15 While access to referred 
management services has been suggested as a barrier to patient care in rural environments 
and the decisions taken by these patients may have been influenced by distances and logistics 
of distant referrals, the counter argument that must be considered is whether further 
investigation to lead to further intervention is not consented or indeed contraindicated 
considering co-morbidities and life expectancy. While patients can be reassured that these 
findings indicate rural practices are finding thin, early stage melanoma and manage most of 
these melanoma locally, further research of the reasons for non-referral from rural locations is 
be required.
Our findings indicate that it is more accurate to describe melanoma epidemiology as different 
in inland, rural communities, than what has been previously reported in coastal and 
metropolitan regions and Queensland-wide. These differences warrant further investigation, 
but appear to arise from being able to gather comprehensive data in rural communities, where 
probable differences in sun exposure and protection behaviours contribute to different 
subtype and anatomic distributions of melanoma; and the model of health services available 
from rural GP finding melanoma earlier and managing them locally. 
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Table 1: Age distribution of patients diagnosed with melanoma
Age group Darling Downs Queensland
(years) no. (% ) [95% CI] no. (%)  [95% CI]
<30 4 (1.3) [0.4-3.0] 193 (4.6) [4.0-5.2]
30-39 15 (4.7) [2.8-7.5] 307 (7.3) [6.5-8.1]
40-49 30 (9.5) [6.6-13.1] 534 (12.7) [11.7-13.7]
50-59 43 (13.6) [10.1-17.7] 702 (16.6) [15.5-17.8]
60-69 73 (23.0) [18.6-27.9] 862 (20.4) [19.2-21.7]
70-79 91 (28.7) [23.9-33.9] 994 (23.6) [22.3-24.9]
80+ 61 (19.2) [15.2-23.9] 626 (14.8) [13.8-15.9]





























































Table 2: Anatomical distribution and relative tumour density of melanoma 
Tumour locationǂ and body surface area TotalMelanoma characteristics and 
relative tumour densitya Head and neck 9%
No. (%) [95% CI]
Trunk 32%
No. (%) [95% CI]
Upper limb 19%
No. (%) [95% CI]
Lower limb 40%
No. (%) [95% CI]
No. of melanoma by location:
Queensland Registryb 747 (23.0) [22-24] 1194 (36.7) [35-38] 633 (19.5) [18-21] 679 (20.9) [20-22] 3253
Qld RTD 2.55 [2.44-2.67] 1.15 [1.09-1.19] 1.02 [0.95-1.11] 0.52 [0.05-0.55]
Darling Downs series 67 (21.1) [17-26] 117 (36.9) [32-42] 82 (25.9) [21-31] 51 (16.1) [12-20] 317
DD RTD 2.35 [1.89-2.88] 1.15 [1.00-1.31] 1.36 [1.11-1.63] 0.40 [0.30-0.050]
Type of melanoma:
Superficial Spreading Melanoma 19 (12.8) [8-19] 60 (40.5) [33-49] 39 (26.4) [20-34] 30 (20.3) [14-27] 148
SSM RTD 1.43 [0.89-2.11] 1.27 [1.03-1.53] 1.39 [1.05-1.79] 0.51 [0.35-0.68]
Lentigo maligna melanoma 35 (36.8) [28-47] 25 (26.3) [18-36] 22 (23.2) [16-32] 13 (13.7) [8-22] 95
LMM RTD 4.09 [3.11-5.22] 0.82 [0.56-1.13] 1.22 [0.84-1.68] 0.34 [0.20-0.55]
Nodular melanoma 3 (15.8) [4-37] 3 (15.8) [4-37] 11 (57.9) [35-78] 2 (10.5) [2-31] 19
NM RTD 1.75 [0.44-4.11] 0.49 [0.13-1.16] 2.05 [1.84-4.11] 0.26 [0.05-0.78]
Unspecified/Other 10 (18.2) [10-30] 29 (52.7) [40-66] 10 (18.2) [10-30] 6 (10.9) [5-21] 55





























































Tumour locationǂ and body surface area TotalMelanoma characteristics and 
relative tumour densitya Head and neck 9%
No. (%) [95% CI]
Trunk 32%
No. (%) [95% CI]
Upper limb 19%
No. (%) [95% CI]
Lower limb 40%
No. (%) [95% CI]
Depth of invasion:
Depth ≤ 1mm 56 (21.2) [17-27] 103 (39.0) [33-45] 59 (22.3) [18-28] 46 (17.4) [13-22] 264
RTD ≤ 1mm depth 2.36 [1.89-3.00] 1.22 [1.03-1.41] 1.18 [0.95-1.47] 0.44 [0.33-0.55]
Depth 1.01-2.0mm 5 (27.8) [11-51] 4 (22.2) [8-45] 8 (44.4) [23-67] 1 (5.6) [1-25] 18
RTD 1.01-2.0mm depth 3.09 [1.22-5.67] 0.69 [0.25-1.41] 2.34 [1.21-3.52] 0.14 [0.03-0.63]
Depth 2.01-4mm 2 (15.4) [3-42] 3 (23.1) [6-51] 7 (53.8) [27-79] 1 (7.7) [1-33] 13
RTD 2.01-4mm depth 1.71 [0.33-4.67] 0.72 [0.19-1.59] 2.83 [1.42-4.16] 0.19 [0.03-0.83]
Depth >4mm 1 (12.5) [1-48] 0 (0) 5 (62.5) [28-89] 2 (25.0) [4-61] 8
RTD >4mm depth 1.39 [0.11-5.33] 0 [0-0] 3.29 [1.47-4.68] 0.63 [0.10-1.53]
aCalculated as the ratio of the proportion of tumours at a specific anatomical site to the proportion of skin surface area at that site, ratio and [95% CI].
b Whiteman D, Baade P, Olsen C (2005).
Abbreviations: RTD, relative tumour density; SSM, Superficial Spreading Melanoma; LM/LMM, Lentigo Maligna/Lentigo Maligna Melanoma; NM, Nodular Melanoma
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